US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 16, 2019 (8 years ago)

Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.

What was recalled

Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For institutional use only, Mfg by: Aenova Holding GmBh, Miami, Fl 33186, NDC 63739-0478-10

Recalling firm
Rx Pak Division of McKesson Corporation
NDC code
63739-0478-10
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1007-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Docusate recalls

See all